CD4 and neoplasm: Similar mechanisms have been described with CD4+ Tregs, whereby tumor cells induce the proliferation of tumor antigen-specific, suppressive CD4+ Tregs through the direct and indirect presentation of human leukocyte antigen (HLA) class II tumor antigens6.